BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation, the Life Science business of Merck KGaA of Germany, that operates as EMD Millipore in the U.S. and Canada, today announced that all its remaining outstanding 3.75% Convertible Senior Notes Due 2026 (the “Notes”) were redeemed on December 1, 2011, at one hundred percent (100%) of the outstanding principle amount of the Notes.
